   ***** *** ********* Progress Note */**/****  CC: Medical Eye Examination     HPI: ****** * ******* is a 82 y.o. male  Patient returns for medical eye exam and Glaucoma follow up.    Patient states his eyes are comfortable and that he feels he sees fine.  He does not have any desire to replace his current lenses or ******.    Current Ocular meds:  Latanoprost Q HS **      ***:  Ocular History:  Pseudophakia, OU, (OD */*/**, ** */****)  Low tension glaucoma, **  ****** Hemorrhage OD (*/**, */**)    Ocular family History:   Mother - Glaucoma  History   Smoking Status   • Former Smoker   Smokeless Tobacco   • Current User      Past Medical History:   Diagnosis Date   • Cataract     resolved with IOL OU   • Glaucoma     LTG, see problem list     FH:   Family History   Problem Relation   • Glaucoma Mother   • Macular degeneration Neg Hx     ROS     Positive for: Eyes    Negative for: Constitutional, Gastrointestinal, Neurological, Skin, Genitourinary, Musculoskeletal, HENT, Endocrine, Cardiovascular, Respiratory, Psychiatric, Allergic/Imm, Heme/Lymph    Last edited by ******** ****** on */**/**** 10:51 AM. (History)         Allergies   Allergen Reactions   • Timolol Pruritus     Current Outpatient Prescriptions (Ophthalmic Medications)   Medication Sig   • latanoprost Instill 1 drop into both eyes once daily in the evening.     Current Outpatient Prescriptions (Other)   Medication Sig   • naproxen sodium Take  by mouth as needed.      EXAM:  See Ophthalmology Module for Examination         Diagnostic Studies:  No diagnostic studies ordered this encounter.      IMPRESSION: 82 y.o. male with Ophthalmologic problems:   1. Primary open angle glaucoma, likely low-tension variant OU, mild to moderate stage OU  -reviewed previous testing  -bilateral thinning on *** RNFL OU. Stable when compared to prior scan.  -**** show early sup/inf nasal steps/******** **>OD  -thin pachy, +fam hx; no gonio noted in paper chart  -IOP excellent, low teens today  -ON appearance stable; excavated cups  -discussed possibility of SLT or additional IOP meds in the future  2. Pseudophakia, OU, tr PCO OD  3. Mild dry eye, asymptomatic  4. Posterior vitreous detachments OU         PLAN:  